Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma

被引：49
|
作者：
Ortega, Hector [1 ]
Katz, Lynn [1 ]
Gunsoy, Necdet [2 ]
Keene, Oliver [2 ]
Yancey, Steven [1 ]
机构：
[1] GlaxoSmithKline, Resp Therapeut Area, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Clin Stat, Stockley Pk, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2015年 / 136卷 / 03期
关键词：
MEPOLIZUMAB;
D O I：
10.1016/j.jaci.2015.05.039
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：825 / +
页数：2
相关论文
共 50 条
  • [41] Eosinophil count in induced sputum is more sensitive than in peripheral blood to phenotype patients with severe eosinophilic asthma
    Nin Valencia, A. R. C.
    Sanchez Ocando, H.
    Caballero, M. L.
    Barranco, P.
    Dominguez Ortega, J.
    Romero, D.
    Luna, A.
    Lopez Carrasco, V
    Quirce, S.
    ALLERGY, 2020, 75 : 397 - 397
  • [42] Efficacy of tezepelumab in patients with severe, uncontrolled asthma and low blood eosinophil counts not receiving maintenance oral corticosteroids
    Menzies-Gow, A.
    Cook, B.
    Colice, G.
    Hellqvist, A.
    Llanos-Ackert, J. P.
    Ambrose, C. S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Real life data on treatment response to mepolizumab in patients with severe eosinophilic asthma
    Ntakoula, M.
    Fokoloros, C.
    Pasali, M.
    Aggelides, X.
    Makris, M.
    ALLERGY, 2019, 74 : 446 - 446
  • [44] Real-World Response To Anti-Eosinophil Biologics For Severe Eosinophilic Asthma
    Surjancev, Ivana
    Viswanathan, Ravi
    Denlinger, Loren
    Mathur, Sameer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB18 - AB18
  • [45] Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients
    Watanabe, Hirofumi
    Shirai, Toshihiro
    Hirai, Keita
    Akamatsu, Taisuke
    Nakayasu, Hiromasa
    Tamura, Kanami
    Masuda, Toshihiro
    Takahashi, Shingo
    Tanaka, Yuko
    Kishimoto, Yutaro
    Oishi, Kyohei
    Saigusa, Mika
    Yamamoto, Akito
    Morita, Satoru
    Asada, Kazuhiro
    JOURNAL OF ASTHMA, 2022, 59 (09) : 1796 - 1804
  • [46] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [47] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [48] The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma
    Ozgen, Hasan
    Tepetam, Fatma Merve
    Bulut, Ismet
    Orcen, Cihan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (01): : 39 - 48
  • [49] Effect Of Mepolizumab On Health Status, Lung Function And Asthma Control According To Baseline Blood Eosinophil Count In Patients With Severe Eosinophilic Asthma
    Trevor, J. L.
    Albers, F. C.
    Nelsen, L. M.
    Bratton, D. J.
    Wang-Jairaj, J.
    Bradford, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [50] Serum total IgE levels and total eosinophil counts: relationship with treatment response in patients with acute asthma
    Razi, Ebrahim
    Moosavi, Gholam Abbass
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2010, 36 (01) : 23 - 28
12345